Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
Saved in:
Main Authors: | Krishnagopal Srikanth, V Sridhanya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Indian Journal of Ophthalmology |
Online Access: | https://journals.lww.com/10.4103/IJO.IJO_2424_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy, safety, and tolerability of lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
by: Namrata Sharma, et al.
Published: (2025-01-01) -
Therapeutic Potential of Combined 5% Lifitegrast and Tocopherol Eye Drops in Managing Inflammation and Oxidative Stress in Murine Dry Eye
by: Jayoung Moon, et al.
Published: (2025-01-01) -
Lifitegrast in Treatment of Dry Eye Disease—A Practical, Narrative Expert Review
by: Erlend C. S. Landsend, et al.
Published: (2025-01-01) -
Safety and Efficacy of Hydroxypropyl Guar-Hyaluronic Acid Dual-Polymer Lubricating Eye Drops in Indian Subjects with Dry Eye: A Phase IV Study
by: Deborah Awisi-Gyau, et al.
Published: (2024-12-01) -
Clinical experience with cyclosporine eye drops for severe dry eye
by: O.I. Lebedev, et al.
Published: (2019-04-01)